Femara (letrozole) is a nonsteroidal aromatase inhibitor that reduces estrogen production by inhibiting the aromatase enzyme. Lowering estrogen levels helps slow or stop the growth of hormone receptor-positive breast cancer cells. Femara is indicated for the adjuvant treatment of early breast cancer, extended adjuvant treatment after standard tamoxifen therapy, and for advanced breast cancer in postmenopausal women. . Please Note that product description, color, ingredients, package and other information maybe different from the original pack kindly check the product for more accurate details.
